Rex Medical Announces The Successful Clinical Retrieval Of The Option(TM) Vena Cava Filter Up To Day 107 In An International Clinical Study
Published: Jan 19, 2007
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Rex Medical, L.P., today announced the successful retrieval of the Option™ Vena Cava Filter in an international clinical study. Twenty-nine patients enrolled to date have been successfully implanted with the Option™ Filter for the prevention of Pulmonary Embolism (PE) resulting from blood clots or “Deep Vein Thrombosis” (DVT) under the direction of Adrian A. Ebner, MD, Chief of Interventional Procedures and Cardiovascular Surgery, French Hospital, Asuncion, Paraguay. PE occurs when thromboemboli (or “blood clots”) become dislodged from the deep veins located in the legs and travel through the blood stream to the lungs. If left untreated, PE has a mortality rate in excess of 30%.